Deepa Rangachari

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO oncology practice

Cancer cytopathology

Beth Israel Deaconess Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Beth Israel Deaconess Medical Center

United States

Assistant Professor :: Medicine

Publications

Andrew J Piper-Vallillo, Hollis Viray, Jill Feldman, Deepa Rangachari
Management of Treatment Resistance in Patients With Advanced Epidermal Growth Factor Receptor-Mutated Lung Cancer: Personalization, Parsimony, and Partnership. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Shubham Agrawal, Rushad Patell, Laura E Dodge, Jennifer W Pegher, Robert L Coleman, David Michael Waterhouse, Daniel Aaron Roberts, Deepa Rangachari
Defining the Educational Needs for a Community-Based Hematology/Oncology Career: A National Needs Assessment. JCO oncology practice (2024)
Shubham Agrawal, Rushad Patell, Laura E Dodge, Jennifer W Pegher, Robert L Coleman, David Michael Waterhouse, Daniel Aaron Roberts, Deepa Rangachari
Defining the Educational Needs for a Community-Based Hematology/Oncology Career: A National Needs Assessment. JCO oncology practice 20 (6) (2024)
Andrew J Piper-Vallillo, Hollis Viray, Jill Feldman, Deepa Rangachari
Management of Treatment Resistance in Patients With Advanced Epidermal Growth Factor Receptor-Mutated Lung Cancer: Personalization, Parsimony, and Partnership. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Andrew J Piper-Vallillo, Hollis Viray, Jill Feldman, Deepa Rangachari
Management of Treatment Resistance in Patients With Advanced Epidermal Growth Factor Receptor-Mutated Lung Cancer: Personalization, Parsimony, and Partnership. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Paul A VanderLaan, Deepa Rangachari, Daniel B Costa
The rapidly evolving landscape of biomarker testing in non-small cell lung cancer. Cancer cytopathology 129 (3) (2020)

Deepa Rangachari.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Deepa Rangachari